BioCentury
ARTICLE | Financial News

Kolltan completes venture financing

March 31, 2014 7:00 AM UTC

Kolltan Pharmaceuticals Inc., New Haven, Conn. Business: Cancer, Antibodies Date completed: 3/26/14 Type: Venture financing Raised: $60 million Investors: Institutional investor; KLP Enterprises; Deer...